Stay updated on Savolitinib for MET Amplified Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 to reflect an updated document version on the page.
    Difference
    0.0%
    Check dated 2026-03-05T19:54:04.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.1 to v3.4.2. This appears to be a minor platform/version update that does not affect the study information or functionality presented on the page.
    Difference
    0.0%
    Check dated 2026-02-12T02:19:38.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-04T23:15:10.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Glossary is now shown on the page, and the metadata includes 'Last Update Submitted that Met QC Criteria'. The footer also displays 'Revision: v3.4.0' and the older phrasing 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T20:32:26.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the page, replacing the previous v3.3.3 revision. No clinical trial content, eligibility criteria, or location details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:47:43.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a detailed Locations section listing state sites (CA, CT, FL, IL, KS, KY, MO, NY, NC, TX) and removed the standalone per-state location headings. Removed the HHS Vulnerability Disclosure and updated the revision to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T21:13:09.000Z thumbnail image

Stay in the know with updates to Savolitinib for MET Amplified Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.